Loading...
Keywords
Last Name
Institution
 Back to Details

Connection

Mark Clements to Prostatic Neoplasms

This is a "connection" page, showing publications Mark Clements has written about Prostatic Neoplasms.

 
Connection Strength
  
 
 
3.698
  
  1. Rai B, Nordstr?m T, Lantz A, Lund RL, Kuja-Halkola R, Rado M, ?berg S, Hao S, Du X, Clements M. Spatio-temporal variation in prostate cancer testing in Stockholm: A population-based study. PLoS One. 2024; 19(8):e0308254.
    View in: PubMed
    Score: 0.939
  2. Hao S, Karlsson A, Heintz E, Elfstr?m KM, Nordstr?m T, Clements M. Cost-Effectiveness of Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study. Value Health. 2021 12; 24(12):1763-1772.
    View in: PubMed
    Score: 0.761
  3. Hao S, ?stensson E, Eklund M, Gr?nberg H, Nordstr?m T, Heintz E, Clements M. The economic burden of prostate cancer - a Swedish prevalence-based register study. BMC Health Serv Res. 2020 May 20; 20(1):448.
    View in: PubMed
    Score: 0.700
  4. Nordstr?m T, Annerstedt M, Glaessgen A, Carlsson S, Clements M, Abbadi A, Gr?nberg H, J?derling F, Eklund M, Discacciati A. Repeated Prostate Cancer Screening Using Prostate-Specific Antigen Testing and Magnetic Resonance Imaging: A Secondary Analysis of the STHLM3-MRI Randomized Clinical Trial. JAMA Netw Open. 2024 02 05; 7(2):e2354577.
    View in: PubMed
    Score: 0.226
  5. M?ller A, Schwamborn K, Spillmann A, Hoogstraate J, Szulkin R, Akre O, Egevad L, Clements M, Aly M. Travel vaccines are strongly associated to reduced mortality in prostate cancer patients - a real effect or residual confounding? Vaccine. 2022 06 15; 40(27):3797-3801.
    View in: PubMed
    Score: 0.201
  6. Nordstr?m T, Discacciati A, Bergman M, Clements M, Aly M, Annerstedt M, Glaessgen A, Carlsson S, J?derling F, Eklund M, Gr?nberg H. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial. Lancet Oncol. 2021 09; 22(9):1240-1249.
    View in: PubMed
    Score: 0.191
  7. Egevad L, Swanberg D, Delahunt B, Str?m P, Kartasalo K, Olsson H, Berney DM, Bostwick DG, Evans AJ, Humphrey PA, Iczkowski KA, Kench JG, Kristiansen G, Leite KRM, McKenney JK, Oxley J, Pan CC, Samaratunga H, Srigley JR, Takahashi H, Tsuzuki T, van der Kwast T, Varma M, Zhou M, Clements M, Eklund M. Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading. Virchows Arch. 2020 Dec; 477(6):777-786.
    View in: PubMed
    Score: 0.176
  8. Nair-Shalliker V, Bang A, Egger S, Clements M, Gardiner RA, Kricker A, Seibel MJ, Chambers SK, Kimlin MG, Armstrong BK, Smith DP. Post-treatment levels of plasma 25- and 1,25-dihydroxy vitamin D and mortality in men with aggressive prostate cancer. Sci Rep. 2020 05 08; 10(1):7736.
    View in: PubMed
    Score: 0.175
  9. Plym A, Clements M, Voss M, Holmberg L, Stattin P, Lambe M. Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study. BMJ Open. 2020 03 09; 10(3):e032914.
    View in: PubMed
    Score: 0.173
  10. Palsdottir T, Nordstr?m T, Aly M, J?derling F, Clements M, Gr?nberg H, Eklund M. A Unified Prostate Cancer Risk Prediction Model Combining the Stockholm3 Test and Magnetic Resonance Imaging. Eur Urol Oncol. 2019 09; 2(5):490-496.
    View in: PubMed
    Score: 0.157
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.